Get the full picture
Sign in to uncover key details.
Cellular Logistics
Blood & Organ Banks · Wisconsin, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
504 S Rosa Rd Ste 200, Madison, Wisconsi...Phone Number
(608) 217-5567Website
www.cellogistics.comRevenue
<$5 MillionIndustry
About Cellular Logistics
Cellular Logistics specializes in regenerative therapies, particularly through its innovative CFX biomaterial, which is the first therapeutic biomaterial developed using induced pluripotent stem cell technology. Their products aim to prevent heart failure following acute injuries like myocardial infarction and to restore heart function in chronic heart failure by remuscularizing scarred myocardium. The company targets healthcare providers and researchers in the cardiovascular field. Cellular Logistics holds exclusive rights to its products, which are protected by patents in the United States and pending applications internationally.Explore more
Cellular Logistics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cellular Logistics
Compare insights from companies similar to Cellular Logistics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cellular Logistics Tech Stack
A closer look at the technologies used by Cellular Logistics
See more technologies
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cellular Logistics
Sign Up For FreeTo access detailed company insights
Cellular Logistics specializes in regenerative therapies, particularly through its innovative CFX biomaterial, which is the first therapeutic biomaterial developed using induced pluripotent stem cell technology. Their products aim to prevent heart failure following acute injuries like myocardial infarction and to restore heart function in chronic h... Read More
